Cassava Sciences Inc (NASDAQ:SAVA) does about 1.41M shares in volume on a normal day but saw 892236 shares change hands in the recent trading day. The company now has a market cap of 104.83M USD. Its current market price is $2.17, marking an increase of 0.93% compared to the previous close of $2.15. The 52 week high reached by this stock is $42.20 whilst the lowest price level in 52 weeks is $1.15.
The consensus objective for the share price is $2.00, suggesting that the stock has a potential downside of -8.5% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 2 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Hold the stock.
H.C. Wainwright upgraded the stock to “Buy” from Neutral on October 08, 2024 at a price target of $116.
The current price level is 3.78%, 25.71%, and -79.74% away from its SMA20, SMA50, and SMA200 respectively, with the SAVA price moving below the 50-day SMA on current market day. Cassava Sciences Inc (SAVA) stock is up 0.46% over the week and 22.60% over the past month. Its price is -8.05% year-to-date and -89.12% over the past year.
To reach the target analysts have set, the stock logically needs to shrink -8.5 percent from here.
Outstanding shares total 48.31M with insiders holding 12.79% of the shares and institutional holders owning 33.06% of the company’s common stock. The company has a return on investment of -57.04% and return on equity of -70.59%. The beta has a value of -2.02. Price to book ratio is 0.82.
